BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 31412350)

  • 1. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
    Dube Mandishora RS; Rounge TB; Fitzpatrick M; Christiansen IK; Ambur OH; Lagström S; Stray-Pedersen B; Tommasino M; Palefsky J; Chirenje ZM
    PLoS One; 2021; 16(4):e0250426. PubMed ID: 33901223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
    Dube Mandishora RS; Christiansen IK; Chin'ombe N; Duri K; Ngara B; Rounge TB; Meisal R; Ambur OH; Palefsky JM; Stray-Pedersen B; Chirenje ZM
    J Med Virol; 2017 Sep; 89(9):1671-1677. PubMed ID: 28390142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
    Kuguyo O; Dube Mandishora RS; Thomford NE; Makunike-Mutasa R; Nhachi CFB; Matimba A; Dandara C
    PLoS One; 2021; 16(9):e0257324. PubMed ID: 34582476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.
    Sun P; Song Y; Ruan G; Mao X; Kang Y; Dong B; Lin F
    J Gynecol Oncol; 2017 Sep; 28(5):e50. PubMed ID: 28657218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
    Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S
    Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
    Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville).
    Boumba LM; Qmichou Z; Mouallif M; Attaleb M; El Mzibri M; Hilali L; Donatien M; Ennaji MM
    J Med Virol; 2015 Oct; 87(10):1769-76. PubMed ID: 25963674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic distribution of human oncogenic papillomaviruses in sexually active women in Burkina Faso: Central, Central-Eastern and Hauts-Bassins regions.
    Ouedraogo RA; Zohoncon TM; Traore IMA; Ouattara AK; Guigma SP; Djigma FW; Obiri-Yeboah D; Ouedraogo C; Simpore J
    Biomol Concepts; 2020 May; 11(1):125-136. PubMed ID: 32417758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.
    Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Parra D; Pineda AC; Sussmann O; Perez-Prados A; Patarroyo ME; Patarroyo MA
    PLoS One; 2013; 8(2):e56509. PubMed ID: 23418581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.
    Couture MC; Page K; Stein ES; Sansothy N; Sichan K; Kaldor J; Evans JL; Maher L; Palefsky J
    BMC Infect Dis; 2012 Jul; 12():166. PubMed ID: 22839728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.